Elad Levy, a renowned neurosurgeon at the University at Buffalo, holds a 3-D printed model of a patient’s anatomy crafted by bioengineers at the Jacobs Institute. This advanced model allows for optimized surgical procedures, ensuring flawless implementation when patients are ready for implants. Photo: Sandra Kicman

An Overview of the Study

Elad Levy, a neurosurgeon at the University at Buffalo, recently shared results from a pioneering feasibility study on a permanently implanted brain-computer interface (BCI) at the Congress of Neurological Surgeons. This study evaluates Synchron’s innovative device, which allows individuals with severe paralysis to control technology using their thoughts, aiming to restore independence and functionality to their lives.

The Importance of the Technology

The COMMAND trial, which included initial participants from Buffalo, Pittsburgh, and Mount Sinai, marks a significant step in neurotechnology. By employing a minimally invasive endovascular procedure, the BCI connects directly to the brain’s motor cortex, enabling the hands-free operation of devices. Levy highlighted the importance of this technology in giving patients back a sense of agency, reducing reliance on caregivers.

Innovative Partnerships Driving Progress

The collaboration between UB’s Department of Neurosurgery, the Gates Vascular Institute, and the Jacobs Institute has been crucial in refining these procedures. Utilizing advanced 3D printing techniques, the team has created precise models of patients’ anatomy, enhancing surgical outcomes. With plans to expand patient enrollment in 2025, this study underscores UB’s commitment to leading innovations in neurosurgery and improving patient care.

Looking Ahead

As the trial progresses, it not only represents a leap forward for those with paralysis but also offers valuable insights for the next generation of medical professionals at UB. This work is a testament to the potential of advanced technologies to transform lives and the future of medicine.

For more information, you can read the full press release from UBNow here.